Alk1 controls arterial endothelial cell migration in lumenized vessels

Area of Science:

• Vascular Biology
• Genetics
• Developmental Biology

Background:

• Heterozygous loss of activin receptor-like kinase 1 (ALK1) causes hereditary hemorrhagic telangiectasia (HHT).
• HHT is characterized by fragile arteriovenous malformations (AVMs).
• The cellular mechanisms linking reduced ALK1 signaling to AVM formation remain unclear.

Purpose of the Study:

• To investigate the cellular behavior of endothelial cells in alk1-deficient zebrafish embryos.
• To elucidate how decreased ALK1 signaling contributes to the development of cranial AVMs.

Main Methods:

• Assessment of endothelial cell behavior in alk1-deficient zebrafish embryos.
• Analysis of endothelial cell proliferation and migration within lumenized vessels.
• Comparison of cell migration patterns in wild-type versus alk1-deficient embryos, considering blood flow direction.

Main Results:

• Alk1 deficiency does not affect arterial endothelial cell proliferation.
• Alk1 loss significantly alters arterial endothelial cell migration, dampening migration against blood flow and enhancing migration with flow.
• This results in fewer endothelial cells in proximal arteries and more in distal arteries, potentially increasing distal arterial caliber.

Conclusions:

• Altered endothelial cell migration, not proliferation, is a key cellular defect caused by alk1 loss.
• The shift in endothelial cell distribution may lead to increased distal arterial caliber and hemodynamic stress, precipitating AVM development.
• Understanding these cellular dynamics provides insight into HHT pathogenesis.